Next year could mark a breakthrough for the Australian e-cigarette market, with the regulator due to review a proposal that e-cigarettes could be allowed subject to a maximum nicotine concentration.
As the latest ECigIntelligence regulatory report makes clear, at present all nicotine-containing products for therapeutic use must be approved as “registered” medicines in the Australian Register of Therapeutic Goods before they can be marketed. To date, no such approval has been granted.
As the latest ECigIntelligence regulatory report makes clear, at present all nicotine-containing products for therapeutic use must be approved as “registered” medicines in the Australian Register of Therapeutic Goods before they can be marketed. To date, no such approval has been granted.
on Mon, 12/05/2016 - 21:28 admin
